---
title: "Hannah Joseph Hospital Ltd (544687) — Share Price, Financials & Analysis"
symbol: "544687"
company: "Hannah Joseph Hospital Ltd"
canonical: "https://tapetide.com/stocks/544687"
isin: "INE0JVH01012"
nse_symbol: "HANNAHJOSEPHHOSPITALLTD"
bse_code: "544687"
sector: "Healthcare"
industry: "Hospital"
market_cap_cr: 254.2
generated_at: "2026-09-13T18:49:38.740Z"
---

# Hannah Joseph Hospital Ltd (544687)

Canonical page: https://tapetide.com/stocks/544687

## Company

- **NSE Symbol:** HANNAHJOSEPHHOSPITALLTD
- **BSE Code:** 544687
- **ISIN:** INE0JVH01012
- **Sector:** Healthcare
- **Industry:** Hospital
- **Macro Sector:** Healthcare
- **Stock Type:** EQUITY
- **Listed Since:** 2026-02-02
- **Face Value:** ₹10
- **F&O Eligible:** No
- **Website:** hannahjosephhospital.com

## About

Incorporated in 2011, Hannah Joseph Hospital Limited is a healthcare provider offering exceptional medical services across various specialties.[1]

## Latest Price

## Key Fundamentals

Observed at 2026-09-11T04:34:05.074476Z.

- **Market Cap:** ₹254.2 Cr
- **Classification:** SME
- **P/E (reported):** 23
- **Book Value:** ₹42.9
- **Price to Book:** 2.65
- **Dividend Yield:** 1.76%
- **ROE:** 11.48%
- **ROCE:** 15.52%
- **Debt to Equity:** 0.28
- **Revenue (yearly):** ₹92.6 Cr
- **Net Income:** ₹11.2 Cr
- **EBITDA:** ₹25.7 Cr
- **52-Week High:** ₹128.8
- **52-Week Low:** ₹55.99
- **RSI (14):** 49.13

## Key Insights

### Strengths

- Company has reduced debt.
- Company has delivered good profit growth of 46.3% CAGR over last 5 years
- Debtor days have improved from 29.0 to 16.1 days.

### Weaknesses

- Company has a low return on equity of 13.7% over last 3 years.

## Growth Rates

| Metric | 1Y | 3Y | 5Y |
| --- | --- | --- | --- |
| cash flow growth | 6.49% | 157.53% | 36.05% |
| ebitda margin growth | 2.74% | -3.74% | -11.7% |
| net income growth | 55.56% | 121% | 46% |
| revenue growth | 18.87% | 19% | 21% |
| roce | -7.95% | 17.93% | 13.1% |
| roe | -17.29% | 11.42% | 737.96% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2025 | Sep 2025 | Mar 2026 |
| --- | --- | --- | --- |
| Sales | 37 | 43 | 50 |
| Expenses | 28 | 31 | 36 |
| Operating Profit | 9 | 12 | 13 |
| OPM % | 25 | 28 | 27 |
| Other Income | 0 | 0 | 0 |
| Interest | 2 | 2 | 1 |
| Depreciation | 4 | 3 | 3 |
| Profit before tax | 4 | 7 | 9 |
| Tax % | 26 | 27 | 32 |
| Net Profit | 3 | 5 | 6 |
| EPS in Rs | 1.87 | 3.07 | 2.67 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2021 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- |
| Sales | 36 | 55 | 63 | 78 | 92 |
| Expenses | 28 | 38 | 45 | 57 | 67 |
| Operating Profit | 7 | 17 | 18 | 21 | 25 |
| OPM % | 21 | 30 | 29 | 27 | 27 |
| Other Income | 2 | 0 | 0 | 0 | 1 |
| Interest | 5 | 6 | 5 | 3 | 3 |
| Depreciation | 7 | 9 | 8 | 7 | 7 |
| Profit before tax | -2 | 1 | 5 | 10 | 16 |
| Tax % | 0 | 0 | 24 | 30 | 30 |
| Net Profit | -2 | 1 | 4 | 7 | 11 |
| EPS in Rs | -13.86 | 0.62 | 2.44 | 4.32 | 4.93 |
| Dividend Payout % | 0 | 0 | 0 | 0 | 0 |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2021 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- |
| Equity Capital | 2 | 16 | 17 | 17 | 23 |
| Reserves | 23 | 18 | 29 | 35 | 75 |
| Borrowings | 57 | 43 | 32 | 37 | 27 |
| Other Liabilities | 13 | 15 | 13 | 8 | 9 |
| Total Liabilities | 94 | 92 | 90 | 97 | 133 |
| Fixed Assets | 86 | 71 | 65 | 69 | 73 |
| CWIP | 0 | 0 | 0 | 1 | 5 |
| Investments | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 8 | 21 | 25 | 27 | 55 |
| Total Assets | 94 | 92 | 90 | 97 | 133 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2021 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 7 | 21 | 8 | 19 | 21 |
| Cash from Investing Activity | -8 | -5 | -4 | -14 | -49 |
| Cash from Financing Activity | 2 | -10 | -3 | -3 | 25 |
| Net Cash Flow | 1 | 5 | 2 | 3 | -3 |
| Free Cash Flow | -1 | 17 | 6 | 7 | 6 |
| CFO/OP | 105 | 126 | 44 | 109 | 101 |

### Ratios

| Item | Mar 2021 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- |
| Debtor Days | 22 | 37 | 46 | 25 | 16 |
| Inventory Days | 54 | 73 | 54 | 47 | 51 |
| Days Payable | 176 | 136 | 102 | 90 | 97 |
| Cash Conversion Cycle | -101 | -25 | -2 | -18 | -30 |
| Working Capital Days | -81 | -83 | -11 | -28 | -17 |
| ROCE % | — | — | 13 | 17 | 18 |

## Shareholding Pattern

### Quarterly

| Category | Mar 2025 | Mar 2026 |
| --- | --- | --- |
| Promoters | 93.57% | 71.28% |
| FIIs | 0% | 0.56% |
| DIIs | 0% | 9.05% |
| Government | 0% | 0% |
| Public | 0% | 12.2% |
| Others | 6.43% | 6.91% |
| No. of Shareholders | 36 | 376 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Sell
- **Buy / Neutral / Sell:** 5 / 7 / 7

### Moving Averages — summary: **Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 115.16 | Sell |
| EMA (10) | 114.05 | Sell |
| SMA (20) | 113.81 | Sell |
| EMA (20) | 113.41 | Sell |
| SMA (50) | 111.92 | Sell |
| EMA (50) | 109.2 | Buy |
| SMA (100) | 99.12 | Buy |
| EMA (100) | 98.38 | Buy |
| SMA (200) | — | Neutral |
| EMA (200) | — | Neutral |

### Oscillators — summary: **Neutral**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 45.94 | Neutral |
| MACD (12,26,9) | 1.24 | Sell |
| Stochastic (14,3,3) | 29.73 | Neutral |
| ADX (14) | 15.23 | Neutral |
| Williams %R (14) | -100 | Buy |
| ATR (14) | 3.8 | High Volatility |
| ROC (12) | -6.62 | Sell |
| Stoch RSI (14) | 0 | Buy |
| UO (7,14,28) | 41.07 | Neutral |

## Filings & Documents

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-09-09 | [Intimation Under Regulation 30 Of SEBI (LODR) Regulations 2015 - Receipt Of Award](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e304be4a-8295-4f48-995d-588432d81ae1.pdf) |
| 2026-09-01 | [Intimation Under Regulation 30 Of SEBI (LODR) Regulations 2015 - Receipt Of Award](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5a302239-143b-407a-a33e-f94e1ae06dfd.pdf) |
| 2026-08-11 | [Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7D99A399_BAD8_48D3_B1E8_3CD1B1AA99BF_131919.pdf) |
| 2026-07-16 | [Shareholder Meeting / Postal Ballot-Scrutinizers Report](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1e9b20e2-8a0c-4c08-acc2-84e16774a571.pdf) |
| 2026-07-15 | [Shareholder Meeting / Postal Ballot-Outcome of AGM](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bc9a9e8e-f1df-4d6e-8f7f-4d20023233e6.pdf) |
| 2026-07-08 | [Announcement under Regulation 30 (LODR)-Press Release / Media Release](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=de40b816-f4b6-4241-8d25-df3e6d7ad84d.pdf) |
| 2026-07-04 | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=958e6aa0-5078-46f2-b979-0d8e92cbb223.pdf) |
| 2026-06-19 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e387667a-ec66-4d5c-9573-cb6de10d316b.pdf) |
| 2026-06-18 | [Reg. 34 (1) Annual Report.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=edf4ea1c-85bf-43ad-94ab-45207e3df30e.pdf) |
| 2026-06-16 | [Notice Of 15Th Annual General Meeting Of The Company Scheduled To Be Held On July 15 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c1270e5c-f558-4249-ae17-7d0dce97b9bd.pdf) |

### Investor Presentations

| Date | Document |
| --- | --- |
| 2026-06-16 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2dc0e34c-8590-40c6-b5ba-57e4bea365b5.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-05-29 | [Audited Financial Results For The Half Year And Year Ended March 31 2026.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5c6ff668-8da1-4f3f-9d69-d5af331c2466.pdf) |

### Other Documents

| Date | Document |
| --- | --- |
| 9h - Company states it is not a large corporate; outstanding borrowing was 25.09 Cr as of 31 March 2026. | [Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A 9h - Company states it is not a large corporate; outstanding borrowing was 25.09 Cr as of 31 March 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/741ea34b-7ab2-4282-ad3e-d9e756d3d6e4.pdf) |
| 9 Mar - Capitalsquare bought 862,000 shares on 02-02-2026; total holding 1,162,000 (5.12%) in Hannah Joseph Hospital. | [Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011 9 Mar - Capitalsquare bought 862,000 shares on 02-02-2026; total holding 1,162,000 (5.12%) in Hannah Joseph Hospital.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/DE1F97C0_D32D_4D9A_807B_A9331675E99D_102545.pdf) |
| 8 November 2025 - Board approved unaudited Q2 and H1 results for period ended 30 Sep 2025; limited review enclosed. | [Outcome of Board Meeting 8 November 2025 - Board approved unaudited Q2 and H1 results for period ended 30 Sep 2025; limited review enclosed.](https://nsearchives.nseindia.com/corporate/SHRENIK_08112025163847_Covering_Letter_for_Outcome_of_bm.pdf) |
| 7 March 2026 - RTA confirms Regulation 74(5) compliance for quarter ended 30 Sep 2025; no demat/remat requests. | [Certificate under SEBI (Depositories and Participants) Regulations, 2018 7 March 2026 - RTA confirms Regulation 74(5) compliance for quarter ended 30 Sep 2025; no demat/remat requests.](https://nsearchives.nseindia.com/corporate/SHRENIK_07032026185338_2.pdf) |
| 7 March 2026 - Confirmation certificate under Regulation 74(5) for quarter ended 30 June 2025; no demat/remat requests. | [Certificate under SEBI (Depositories and Participants) Regulations, 2018 7 March 2026 - Confirmation certificate under Regulation 74(5) for quarter ended 30 June 2025; no demat/remat requests.](https://nsearchives.nseindia.com/corporate/SHRENIK_07032026185024_1.pdf) |
| 7 March 2026 - Certificate under SEBI Regulation 74(5) confirming dematerialisation activities for quarter ended 31 December 2025. | [Certificate under SEBI (Depositories and Participants) Regulations, 2018 7 March 2026 - Certificate under SEBI Regulation 74(5) confirming dematerialisation activities for quarter ended 31 December 2025.](https://nsearchives.nseindia.com/corporate/SHRENIK_07032026185540_3.pdf) |
| 7 Mar - Yuvaraj Saravanan appointed Company Secretary/Compliance Officer Oct 11, 2022; continues post BSE SME listing (Feb 2, 2026). | [Intimation Under Regulation 6(1) Of The SEBI (LODR) Regulations 2015 7 Mar - Yuvaraj Saravanan appointed Company Secretary/Compliance Officer Oct 11, 2022; continues post BSE SME listing (Feb 2, 2026).](https://www.bseindia.com/xml-data/corpfiling/AttachHis/6382c703-8f57-48f8-8c71-4ca48cdc28fa.pdf) |
| 7 Mar - BTS Consultancy remains Registrar & Share Transfer Agent since 29-Nov-2021; disclosure filed 07-Mar-2026. | [Announcement under Regulation 30 (LODR)-Change in RTA 7 Mar - BTS Consultancy remains Registrar & Share Transfer Agent since 29-Nov-2021; disclosure filed 07-Mar-2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/8e4c5bdc-0846-4443-a435-ea7d3aa5d5bb.pdf) |
| 6 Mar - Filed Code for fair disclosure (SEBI PIT); Board approved 19-12-2024; intimated 06-03-2026. | [Intimation Under Regulation 8(2) Of The Securities Exchange Board Of India (Prohibition Of Insider Trading) Regulations 2015 6 Mar - Filed Code for fair disclosure (SEBI PIT); Board approved 19-12-2024; intimated 06-03-2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/27c98f2a-4b7d-4a0a-8728-0652d8b99786.pdf) |
| 6 Apr - SMP Dr. Natarajan Arunkumar acquired 26,000 shares on 05.02.2026, 13.03.2026, and 30.03.2026. | [Intimation Of Disclosure Under Regulation 7(2)(B) Of The SEBI (Prohibition Of Insider Trading) Regulations 2015 6 Apr - SMP Dr. Natarajan Arunkumar acquired 26,000 shares on 05.02.2026, 13.03.2026, and 30.03.2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/7ee5780f-5092-43cc-bd5e-7252e5a1e0c9.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from nse | [Financial Year 2024 from nse](https://archives.nseindia.com/annual_reports/AR_25961_SHRENIK_2023_2024_06092024141256.pdf) |
| from nse | [Financial Year 2023 from nse](https://archives.nseindia.com/annual_reports/AR_23383_SHRENIK_2022_2023_04092023171210_09042023180041.zip) |
| from nse | [Financial Year 2022 from nse](https://archives.nseindia.com/annual_reports/AR_21494_SHRENIK_2021_2022_06092022165120_09062022170020.zip) |
| from nse | [Financial Year 2021 from nse](https://archives.nseindia.com/annual_reports/AR_18998_SHRENIK_2020_2021_28082021175226_08282021180009.zip) |
| from nse | [Financial Year 2020 from nse](https://archives.nseindia.com/annual_reports/AR_17464_SHRENIK_2019_2020_06092020172200_06092020180003.zip) |
| from bse | [Annual Report 2026 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/edf4ea1c-85bf-43ad-94ab-45207e3df30e.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T18:49:38.740Z.